Literature DB >> 11505458

Detection of high-risk HPV types by the hybrid capture 2 test.

G Terry1, L Ho, P Londesborough, J Cuzick, I Mielzynska-Lohnas, A Lorincz.   

Abstract

A hybrid capture test that can be used to detect at least 13 high-risk HPV types (referred to collectively as HPV-HR) in cervical scrapes (Hybrid Capture 2 probe set B, HC2-B) was evaluated. The HC2-B test is accurate and highly reproducible and the results obtained show excellent agreement with those obtained by a multiplexed type-specific polymerase chain reaction (mts-PCR). An additional assay to identify a subset of HPV-HR types may improve specificity without compromising sensitivity in HC2-B positive specimens with a test result close to the cut-off value given by 1 pg/ml HPV DNA. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11505458

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  27 in total

1.  Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program.

Authors:  A T Hesselink; N W J Bulkmans; J Berkhof; A T Lorincz; C J L M Meijer; P J F Snijders
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

2.  Clinical impact of the analytical specificity of the hybrid capture 2 test: data from the New Technologies for Cervical Cancer (NTCC) study.

Authors:  Anna Gillio-Tos; Laura De Marco; Francesca Maria Carozzi; Annarosa Del Mistro; Salvatore Girlando; Elena Burroni; Helena Frayle-Salamanca; Paolo Giorgi Rossi; Paola Pierotti; Guglielmo Ronco
Journal:  J Clin Microbiol       Date:  2013-06-26       Impact factor: 5.948

3.  Optimal threshold for a positive hybrid capture 2 test for detection of human papillomavirus: data from the ARTISTIC trial.

Authors:  A Sargent; A Bailey; A Turner; M Almonte; C Gilham; H Baysson; J Peto; C Roberts; C Thomson; M Desai; J Mather; H Kitchener
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

4.  Prevalence of human papilloma virus infection in women in rural Ethiopia.

Authors:  R Ruland; C Prugger; R Schiffer; M Regidor; R J Lellé
Journal:  Eur J Epidemiol       Date:  2006-10-27       Impact factor: 8.082

5.  Human papillomavirus genotype specificity of hybrid capture 2 low-risk probe cocktail.

Authors:  Mario Poljak; Bostjan J Kocjan; Anja Kovanda; Maja M Lunar; Snjezana Zidovec Lepej; Ana Planinic; Katja Seme; Adriana Vince
Journal:  J Clin Microbiol       Date:  2009-06-03       Impact factor: 5.948

6.  Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results.

Authors:  Matthew P Stevens; Suzanne M Garland; Elice Rudland; Jeffrey Tan; Michael A Quinn; Sepehr N Tabrizi
Journal:  J Clin Microbiol       Date:  2007-05-09       Impact factor: 5.948

7.  Human papillomavirus genotype specificity of hybrid capture 2.

Authors:  Philip E Castle; Diane Solomon; Cosette M Wheeler; Patti E Gravitt; Sholom Wacholder; Mark Schiffman
Journal:  J Clin Microbiol       Date:  2008-06-25       Impact factor: 5.948

8.  The PapilloCheck Assay for Detection of High-Grade Cervical Intraepithelial Neoplasia.

Authors:  Emma J Crosbie; Andrew Bailey; Alex Sargent; Clare Gilham; Julian Peto; Henry C Kitchener
Journal:  J Clin Microbiol       Date:  2015-09-02       Impact factor: 5.948

9.  Papanicolaou tests and molecular analyses using new fluid-based specimen collection technology in 3000 Japanese women.

Authors:  N Masumoto; T Fujii; M Ishikawa; M Mukai; M Saito; T Iwata; T Fukuchi; K Kubushiro; K Tsukazaki; S Nozawa
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

10.  Prevalence and predictors of colposcopic-histopathologically confirmed cervical intraepithelial neoplasia in HIV-infected women in India.

Authors:  Vikrant V Sahasrabuddhe; Ramesh A Bhosale; Smita N Joshi; Anita N Kavatkar; Chandraprabha A Nagwanshi; Rohini S Kelkar; Cathy A Jenkins; Bryan E Shepherd; Seema Sahay; Arun R Risbud; Sten H Vermund; Sanjay M Mehendale
Journal:  PLoS One       Date:  2010-01-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.